Prevalence and causes of failure of receiving thrombolytic therapy in patients with acute ST-segment elevation myocardial infarction

Background: Missing thrombolytic therapy in patients with acute ST-elevation myocardial infarction (STEMI) can have dire consequences. We studied the prevalence and causes of failure of receiving thrombolytic therapy in patients with STEMI and its impact on the clinical outcome during hospitalizatio...

Full description

Bibliographic Details
Main Authors: R. Taha, M. Oraby, G. Nasr, A. El-Hawary
Format: Article
Language:English
Published: SpringerOpen 2013-06-01
Series:The Egyptian Heart Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1110260812000671
_version_ 1818217943856578560
author R. Taha
M. Oraby
G. Nasr
A. El-Hawary
author_facet R. Taha
M. Oraby
G. Nasr
A. El-Hawary
author_sort R. Taha
collection DOAJ
description Background: Missing thrombolytic therapy in patients with acute ST-elevation myocardial infarction (STEMI) can have dire consequences. We studied the prevalence and causes of failure of receiving thrombolytic therapy in patients with STEMI and its impact on the clinical outcome during hospitalization. Patients and methods: This was an observational, analytic, cross sectional study carried out in the CCU and emergency departments of three public hospitals in Port Said, Egypt. We interrogated all patients admitted within 72 h of possible acute coronary syndrome and only patients proved to have STEMI as defined by the updated ACC criteria were analyzed for receiving thrombolytic therapy or not. All STEMI patients were subjected to: medical history taking, thorough clinical examination, 12-leads surface electrocardiography, cardiac biomarkers (troponin I), and predischarge trans-thoracic echocardiography. Results: Of 6522 patients screened, only 288 patients had STEMI. The prevalence of missed thrombolysis in these patients was 45%. Delayed presentation after the onset of symptoms represented the most common cause for failure to receive thrombolysis (54% of the cases), while misdiagnosis at the emergency department represented 35% of the cases. Female gender, diabetes mellitus and inferior location of myocardial infarction were independent predictors of missed thrombolytic therapy. Cardiac death, clinical heart failure and significant cardiac dysrhythmias were higher in patients who missed thrombolysis than in those who received it. Conclusion: In this study, up to 45% of patients with STEMI missed the opportunity to receive thrombolysis, most likely due to delayed presentation or misdiagnosis at the emergency department. Patients with missed thrombolysis were at higher risk of cardiac death, clinical heart failure, and hemodynamically significant cardiac dysrhythmias.
first_indexed 2024-12-12T07:15:54Z
format Article
id doaj.art-40b4f618613d4767a1bab33c1c8b8fc2
institution Directory Open Access Journal
issn 1110-2608
language English
last_indexed 2024-12-12T07:15:54Z
publishDate 2013-06-01
publisher SpringerOpen
record_format Article
series The Egyptian Heart Journal
spelling doaj.art-40b4f618613d4767a1bab33c1c8b8fc22022-12-22T00:33:31ZengSpringerOpenThe Egyptian Heart Journal1110-26082013-06-01652515510.1016/j.ehj.2012.05.002Prevalence and causes of failure of receiving thrombolytic therapy in patients with acute ST-segment elevation myocardial infarctionR. TahaM. OrabyG. NasrA. El-HawaryBackground: Missing thrombolytic therapy in patients with acute ST-elevation myocardial infarction (STEMI) can have dire consequences. We studied the prevalence and causes of failure of receiving thrombolytic therapy in patients with STEMI and its impact on the clinical outcome during hospitalization. Patients and methods: This was an observational, analytic, cross sectional study carried out in the CCU and emergency departments of three public hospitals in Port Said, Egypt. We interrogated all patients admitted within 72 h of possible acute coronary syndrome and only patients proved to have STEMI as defined by the updated ACC criteria were analyzed for receiving thrombolytic therapy or not. All STEMI patients were subjected to: medical history taking, thorough clinical examination, 12-leads surface electrocardiography, cardiac biomarkers (troponin I), and predischarge trans-thoracic echocardiography. Results: Of 6522 patients screened, only 288 patients had STEMI. The prevalence of missed thrombolysis in these patients was 45%. Delayed presentation after the onset of symptoms represented the most common cause for failure to receive thrombolysis (54% of the cases), while misdiagnosis at the emergency department represented 35% of the cases. Female gender, diabetes mellitus and inferior location of myocardial infarction were independent predictors of missed thrombolytic therapy. Cardiac death, clinical heart failure and significant cardiac dysrhythmias were higher in patients who missed thrombolysis than in those who received it. Conclusion: In this study, up to 45% of patients with STEMI missed the opportunity to receive thrombolysis, most likely due to delayed presentation or misdiagnosis at the emergency department. Patients with missed thrombolysis were at higher risk of cardiac death, clinical heart failure, and hemodynamically significant cardiac dysrhythmias.http://www.sciencedirect.com/science/article/pii/S1110260812000671STEMIDelayed presentationMissed thrombolysis
spellingShingle R. Taha
M. Oraby
G. Nasr
A. El-Hawary
Prevalence and causes of failure of receiving thrombolytic therapy in patients with acute ST-segment elevation myocardial infarction
The Egyptian Heart Journal
STEMI
Delayed presentation
Missed thrombolysis
title Prevalence and causes of failure of receiving thrombolytic therapy in patients with acute ST-segment elevation myocardial infarction
title_full Prevalence and causes of failure of receiving thrombolytic therapy in patients with acute ST-segment elevation myocardial infarction
title_fullStr Prevalence and causes of failure of receiving thrombolytic therapy in patients with acute ST-segment elevation myocardial infarction
title_full_unstemmed Prevalence and causes of failure of receiving thrombolytic therapy in patients with acute ST-segment elevation myocardial infarction
title_short Prevalence and causes of failure of receiving thrombolytic therapy in patients with acute ST-segment elevation myocardial infarction
title_sort prevalence and causes of failure of receiving thrombolytic therapy in patients with acute st segment elevation myocardial infarction
topic STEMI
Delayed presentation
Missed thrombolysis
url http://www.sciencedirect.com/science/article/pii/S1110260812000671
work_keys_str_mv AT rtaha prevalenceandcausesoffailureofreceivingthrombolytictherapyinpatientswithacutestsegmentelevationmyocardialinfarction
AT moraby prevalenceandcausesoffailureofreceivingthrombolytictherapyinpatientswithacutestsegmentelevationmyocardialinfarction
AT gnasr prevalenceandcausesoffailureofreceivingthrombolytictherapyinpatientswithacutestsegmentelevationmyocardialinfarction
AT aelhawary prevalenceandcausesoffailureofreceivingthrombolytictherapyinpatientswithacutestsegmentelevationmyocardialinfarction